• LAST PRICE
    2.1300
  • TODAY'S CHANGE (%)
    Trending Down-0.0227 (-1.0545%)
  • Bid / Lots
    2.1000/ 15
  • Ask / Lots
    2.3000/ 2
  • Open / Previous Close
    2.1700 / 2.1527
  • Day Range
    Low 2.1000
    High 2.2100
  • 52 Week Range
    Low 1.7100
    High 3.0300
  • Volume
    44,435
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 2.1527
TimeVolumeABIO
09:32 ET2252.17
09:34 ET4002.172
09:36 ET12802.17
09:45 ET5002.18
09:48 ET9002.1701
09:52 ET7002.19
09:56 ET33772.21
10:01 ET3742.1789
10:10 ET6002.2
10:17 ET4282.1715
10:24 ET21002.19
10:26 ET2002.1872
10:32 ET31512.19
10:33 ET35702.16
10:35 ET33002.18
10:44 ET12402.18
10:46 ET7002.1442
10:51 ET21002.17
11:04 ET16502.155
11:27 ET1002.1438
11:31 ET1002.1401
11:33 ET41002.16
11:40 ET1002.16
11:42 ET18002.16
12:14 ET1202.1526
12:30 ET2002.14
12:41 ET3002.14
01:44 ET1002.125
01:57 ET2002.1201
02:00 ET1002.1201
02:18 ET31002.13
02:31 ET14002.12
03:00 ET12002.13
03:48 ET4182.12
03:57 ET6802.125
03:59 ET1602.13
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesABIO
ARCA Biopharma Inc
30.7M
-1.8x
---
United StatesAVRO
AVROBIO Inc
29.9M
-0.3x
---
United StatesKTTA
Pasithea Therapeutics Corp
31.8M
-4.4x
---
United StatesNLTX
Neoleukin Therapeutics Inc
29.3M
-0.6x
---
United StatesDMAC
DiaMedica Therapeutics Inc
32.3M
-2.2x
---
United StatesVRAX
Virax Biolabs Group Ltd
31.9M
-37.1x
---
As of 2022-09-24

Company Information

ARCA biopharma, Inc. (ARCA) is a biopharmaceutical company, which is focused on development and commercialization of targeted therapies for cardiovascular diseases. The Company's lead product includes Recombinant Nematode Anticoagulant Protein c2, or rNAPc2 (AB201) and Gencaro (bucindolol hydrochloride). rNAPc2 (AB201) is a treatment for diseases caused by ribonucleic acid (RNA), viruses, focusing on COVID-19, the disease syndrome caused by the SARS-CoV-2 virus. The gencaro is a pharmacogenetically-targeted beta-adrenergic receptor antagonist with mild vasodilator properties for the treatment of atrial fibrillation (AF) in patients with heart failure. The Company is conducting Phase II b clinical trial of rNAPc2 (AB201). Its ASPEN-COVID-19 Phase IIb is a randomized, multi-center, international clinical trial evaluating two dose regimens of rNAPc2 versus heparin prescribed per local standard of care in hospitalized SARS-CoV-2 positive patients that also have an elevated D-dimer level.

Contact Information

Headquarters
Suite 430, 8001 Arista PlaceBROOMFIELD, CO, United States 80021
Phone
720-940-2200
Fax
302-655-5049

Executives

Independent Chairman of the Board
Robert Conway
President, Chief Executive Officer, Director
Michael Bristow
Chief Financial Officer, Principal Accounting Officer
C. Jeffrey Dekker
Chief Operating Officer
Thomas Keuer
Senior Vice President, General Counsel, Secretary
Christopher Ozeroff

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$30.7M
Revenue (TTM)
$0.00
Shares Outstanding
14.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.90
EPS
$-1.17
Book Value
$3.54
P/E Ratio
-1.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.